Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry

Abstract : The aims of the present study were to describe the proportion of patients eligible for the COMPASS trial within the Reduction of Atherothrombosis for Continued Health (REACH) registry, the reasons for ineligibility, and to put in perspective the characteristics and outcomes of trial-eligible patients from the REACH registry compared with those of patients enrolled in the reference aspirin arm of the COMPASS trial.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-unilim.archives-ouvertes.fr/hal-02043611
Contributeur : Elisabeth Grelier <>
Soumis le : jeudi 21 février 2019 - 10:18:06
Dernière modification le : mardi 1 septembre 2020 - 03:22:14

Lien texte intégral

Identifiants

Citation

Arthur Darmon, Deepak Bhatt, Yedid Elbez, Victor Aboyans, Sonia Anand, et al.. External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry. European Heart Journal, Oxford University Press (OUP): Policy B, 2018, 39 (9), pp.750-757a. ⟨10.1093/eurheartj/ehx658⟩. ⟨hal-02043611⟩

Partager

Métriques

Consultations de la notice

326